Followers | 1076 |
Posts | 26380 |
Boards Moderated | 12 |
Alias Born | 01/11/2016 |
Tuesday, April 09, 2024 4:14:53 PM
Recent ADXN News
- Addex Provides Update on ADX71149 Phase 2 Epilepsy Study • GlobeNewswire Inc. • 04/29/2024 05:00:00 AM
- Addex to Present at the Swiss Biotech Day 2024 • GlobeNewswire Inc. • 04/19/2024 05:00:00 AM
- Addex Therapeutics Reports Full Year 2023 Financial Results and Provides Corporate Update • GlobeNewswire Inc. • 04/18/2024 05:00:00 AM
- Addex Therapeutics to Release Full-Year 2023 Financial Results and Host Conference Call on April 18, 2024 • GlobeNewswire Inc. • 04/11/2024 05:00:00 AM
- Addex and Perceptive Launch Neurosterix with $63 Million to Accelerate Development of Allosteric Modulator Therapeutics for Neurological Disorders • GlobeNewswire Inc. • 04/03/2024 05:00:00 AM
- Addex to Present at the Bio-Europe Spring 2024 Conference • GlobeNewswire Inc. • 03/14/2024 06:00:00 AM
- Addex Enters into At-The-Market ADS Offering Agreement with H.C. Wainwright & Co. LLC. • GlobeNewswire Inc. • 01/31/2024 06:00:00 AM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 01/30/2024 10:00:28 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 01/30/2024 09:58:12 PM
- Addex to Present at the Swiss Equities Baader Conference • GlobeNewswire Inc. • 01/09/2024 06:00:00 AM
- Addex to Present at Biotech Showcase™ 2024 • GlobeNewswire Inc. • 01/05/2024 06:30:00 AM
- Form 6-K/A - Report of foreign issuer [Rules 13a-16 and 15d-16]: [Amend] • Edgar (US Regulatory) • 12/21/2023 11:00:58 AM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 12/20/2023 11:05:05 AM
- Addex Shareholders Approve All Resolutions at Extraordinary General Meeting • GlobeNewswire Inc. • 12/20/2023 06:00:00 AM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 12/14/2023 11:05:09 AM
- Addex Creates Treasury Shares • GlobeNewswire Inc. • 12/14/2023 06:00:00 AM
- Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] • Edgar (US Regulatory) • 12/08/2023 07:11:53 PM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 11/30/2023 09:00:31 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 11/30/2023 05:15:08 AM
- Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] • Edgar (US Regulatory) • 11/29/2023 09:00:17 PM
- Form POS AM - Post-Effective amendments for registration statement • Edgar (US Regulatory) • 11/29/2023 11:27:36 AM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 11/29/2023 11:00:15 AM
- Addex Reports Q3 2023 Financial Results and Provides Corporate Update • GlobeNewswire Inc. • 11/29/2023 06:00:00 AM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 11/28/2023 11:05:04 AM
- Addex Convenes Extraordinary General Meeting • GlobeNewswire Inc. • 11/28/2023 06:00:00 AM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM